E18 Corp. Posts Corporate Profile in BARRON'S Weekly Magazine August 17th Edition

MINNEAPOLIS, MN, Aug 17 (MARKET WIRE) --
E-18 Corp. (OTCBB: ETEN) today announced its corporate profile appears in
BARRON'S Weekly Magazine on Monday August 17th.

The Corporate Profile will be carried in BARRON'S national circulation.

"This reflects a commitment on the part of Protectus Medical Devices to
introducing the Company's revolutionary Hypodermic Safety Syringe
technology to the nation at large," said Dr. John. Salstrom, President and
CEO.

"Our country pays a heavy price for the cost of needlestick injuries every
year, adding an additional burden to our health care industry in the
billions of dollars.

"In addition to the enormous cost to our country's healthcare industry,
there is the horrible human tragedy side of the needlestick injury
problem, namely, that of the nurses, doctors and health care workers who
contract HIV, Hepatitis, and other blood borne diseases from such
needlestick injuries, some cases of which are fatal," Dr. Salstrom
continued.

"The Protectus Hypodermic Safety Syringe will prevent needlestick
injuries, it will save the lives of our nurses, doctors, and health care
workers, and it will contribute to reducing overall health care costs to
our country," Dr. Salstrom said.

"We are pleased to introduce our revolutionary technology to the market
place and we invite everyone to follow the Company's progress by visiting
our website at www.protectusmedical.com."

About E-18 Corp.

E-18 Corp., through its wholly owned subsidiary, SquareOne Medical, Inc.,
doing business as Protectus Medical Devices, develops and markets
innovative safety medical percutaneous devices that, collectively, have
the potential to dramatically reduce needlestick injuries for medical
professionals worldwide. In the nearly $5 billion global hypodermic
syringe market, the Protectus Safety Syringe, the Company's lead product,
is the only fully automatic, self-sheathing hypodermic safety syringe that
currently meets the functional definition of "Self-Sheathing" mandated by
the U.S. Federal Government. None of the manufacturers of other devices on
the market can make this claim. Protectus Medical Devices has successfully
patented its automatic, self-sheathing hypodermic safety syringe product,
and, based on the results of full comparison clinical trials, the
Protectus Safety Syringe (formerly the SquareOne Safety Syringe) has
received the required 510(k) permission from the U.S. FDA to manufacture
and market the device in the U.S. More information about the Company may
be found at www.protectusmedical.com.

Forward-Looking Statements

Under The Private Securities Litigation Reform Act of 1995: The statements
in the press release that relate to the Company's expectations with regard
to the future impact on the Company's results from new products in
development are forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. These statements are
subject to risks and uncertainties. Words such as "expects," "intends,"
"plans," "may," "could," "should," "anticipates," "likely," "believes" and
words of similar import also identify forward-looking statements.
Forward-looking statements are based on current facts and analyses and
other information that are based on forecasts of future results, estimates
of amounts not yet determined and assumptions of management. Readers are
urged not to place undue reliance on the forward-looking statements, which
speak only as of the date of this release. We assume no obligation to
update any forward-looking statements in order to reflect any event or
circumstance that may arise after the date of this release. Additional
information on risks and other factors that may affect the business and
financial results of E-18 Corp. can be found in the filings of E-18 Corp.
with the U.S. Securities and Exchange Commission.

Contact Information
E-18 Corp.
John Salstrom
President and CEO
moreinfo@protectusmedical.com
Ph: 800-778-8438

Copyright 2009, Market Wire, All rights reserved.

-0-